Close

Sciclone Pharmaceuticals, Inc. (SCLN) Posts Mixed Q2 Results

August 8, 2012 4:28 PM EDT Send to a Friend
Sciclone Pharmaceuticals, Inc. (NASDAQ: SCLN) reported Q2 EPS of $0.19 ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login